- Article metrics
- Last updated: Wed, 25 Feb 2026 16:20:53 Z
Phase 2 study of cabazitaxel as second-line treatment in patients with HER2-negative metastatic breast cancer previously treated with taxanes—a Hellenic Cooperative Oncology Group (HeCOG) Trial
Access & Citations
-
- 2673
- Article Accesses
-
- 14
- Citations
Citation counts are provided by Dimensions and depend on their data availability. Counts will update daily, once available.
